AngioDynamics (ANGO) SVP Nighan Warren Jr. Sells Shares

What Happened

• Nighan Warren Jr., Senior Vice President, Quality and Regulatory at AngioDynamics (ANGO), disposed of a total of 3,777 shares in three transactions to satisfy tax-withholding obligations tied to vested restricted stock units (RSUs). The sales were: 2,153 shares @ $14.14 on 2026-07-16 ($30,443), 1,373 shares @ $13.51 on 2026-07-17 ($18,549), and 251 shares @ $13.71 on 2026-07-20 ($3,441). These were exempt dispositions for tax withholding (code F) and are routine sell-to-cover actions, not open-market investment decisions.

Key Details

• Transaction dates and amounts:
  • 2026-07-16: 2,153 shares sold @ $14.14 = $30,443 (F1)
  • 2026-07-17: 1,373 shares sold @ $13.51 = $18,549 (F2)
  • 2026-07-20: 251 shares sold @ $13.71 = $3,441 (F3)
• Total: 3,777 shares; total proceeds ≈ $52,433.
• Footnotes: Each disposition was an exempt sale to satisfy tax withholding for RSU vesting from prior grants dated 7/16/2025 (F1), 7/17/2024 (F2), and 7/20/2022 (F3).
• Transaction code: F — disposition to cover tax withholding on vested equity.
• Shares owned after the transactions: not specified in the provided filing.
• Timeliness: Filing date 2026-07-21. The 7/16 and 7/17 transactions appear to have been reported after the SEC’s typical two-business-day window (i.e., late); the 7/20 transaction was filed within one business day.

Context

• These were sell-to-cover/tax-withholding transactions tied to RSU vesting, a common administrative action that does not necessarily reflect the insider’s view of the company’s prospects. For retail investors, purchases by insiders tend to be more informative than routine withholding sales.